A dual agonist medication like tirzepatide acts as both a GIP and GLP-1 receptor agonist, potentially offering enhanced benefits for diabetes and weight management
The small increased risk of gallbladder problems with Wegovy (2.5% vs 1% with placebo) should be viewed in context
Theres discharge coming from your incision that smells bad or looks like pus (thick and milky)
Ultrathin 2D metalorganic framework nanosheets
Stimulation of stem cells: Research suggests that GHK-Cu can activate dermal papilla cells, the specialized cells at the base of the follicle that control hair growth and thickness
Response rates vary from series to series.104 While an 85% clinical response rate with histologic confirmation has been reported,91 in most cases evaluation was done by punch biopsy of a previously positive area.2 In 3 studies, after initial imiquimod treatment full tumor excision was achieved, with histologic clearance rates of 75%, 63%, and 53%.105108 Progression to LMM was reported during treatment in 3 patients.5,109,110 Because of variations in study design, it is not possible to identify optimal parameters or predictors of treatment failure or absence of response.110,111 Imiquimod has been associated with a hypothetical risk of favoring tumor progression.103,112 One study showed that treatment efficacy was significantly related only to a moderate to severe clinical inflammatory response.113 Different strategies have been used to improve inflammatory response, including increasing frequency of application (twice a day) or using occlusion, cryotherapy, or tazarotene 0.1% in gel.110,114,115 Clinical response should not be used on its own to evaluate treatment response, as clinical and histologic findings may not match (Fig
